Wordt geladen...
Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats
OBJECTIVE: To seek efficient aldose reductase inhibitors (ARIs) with excellent in vitro and in vivo biological activities against rat galactosemic cataract. METHODS: The method was firstly optimized to screen strong ARIs from nonoriented synthetic compounds and natural extracts. Then, diosgenin was...
Bewaard in:
| Gepubliceerd in: | J Diabetes Res |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5605930/ https://ncbi.nlm.nih.gov/pubmed/29038789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7309816 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|